Journal
MICROBIOME
Volume 10, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s40168-021-01208-5
Keywords
Stool metabolites; Gut microbiota; Colorectal adenoma; Biomarker
Categories
Funding
- National Key R&D Program of China [2020YFA 0509200/2020YFA0509203]
- RGC Theme-based Res Scheme Hong Kong [T21-705/20-N]
- RGC [C4039-19GF, C7065-18GF]
- RGC-GRF Hong Kong [14163817]
- Chinese University of Hong Kong
Ask authors/readers for more resources
This study identifies gut microbiota-associated metabolites and their role in colorectal carcinogenesis. Additionally, the integrated analysis of metabolomics and metagenomics profiles reveals the perturbation of gut metabolites and their association with gut microbiota along colorectal carcinogenesis. Fecal metabolites show potential for non-invasive diagnosis of colorectal neoplasia.
Background: Gut microbiota contributes to colorectal cancer (CRC) pathogenesis through microbes and their metabolites. The importance of microbiota-associated metabolites in colorectal carcinogenesis highlights the need to investigate the gut metabolome along the adenoma-carcinoma sequence to determine their mechanistic implications in the pathogenesis of CRC. To date, how and which microbes and metabolites interactively promote early events of CRC development are still largely unclear. We aim to determine gut microbiota-associated metabolites and their linkage to colorectal carcinogenesis. Results: We performed metabolomics and metagenomics profiling on fecal samples from 386 subjects including 118 CRC patients, 140 colorectal adenomas (CRA) patients and 128 healthy subjects as normal controls (NC). We identified differences in the gut metabolite profiles among NC, CRA and CRC groups by partial least squares-discriminant and principal component analyses. Among the altered metabolites, norvaline and myristic acid showed increasing trends from NC, through CRA, to CRC. CRC-associated metabolites were enriched in branched-chain amino acids, aromatic amino acids and aminoacyl-tRNA biosynthesis pathways. Moreover, metabolites marker signature (twenty metabolites) classified CRC from NC subjects with an area under the curve (AUC) of 0.80, and CRC from CRA with an AUC of 0.79. Integrative analyses of metabolomics and metagenomics profiles demonstrated that the relationships among CRC-associated metabolites and bacteria were altered across CRC stages; certain associations exhibited increasing or decreasing strengths while some were reversed from negative to positive or vice versa. Combinations of gut bacteria with the metabolite markers improved their diagnostic performances; CRC vs NC, AUC: 0.94; CRC vs CRA, AUC 0.92; and CRA vs NC, AUC: 0.86, indicating a potential for early diagnosis of colorectal neoplasia. Conclusions: This study underscores potential early-driver metabolites in stages of colorectal tumorigenesis. The Integrated metabolite and microbiome analysis demonstrates that gut metabolites and their association with gut microbiota are perturbed along colorectal carcinogenesis. Fecal metabolites can be utilized, in addition to bacteria, for non-invasive diagnosis of colorectal neoplasia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available